Clorox (NYSE:CLX - Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of $1.36 per share for the quarter. Clorox has set its FY25 guidance at $6.55-$6.80 EPS and its FY 2025 guidance at 6.550-6.800 EPS.Persons that wish to listen to the company's earnings conference call can do so using this link.
Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Clorox Trading Down 0.1 %
Shares of CLX traded down $0.13 during midday trading on Wednesday, hitting $159.04. The stock had a trading volume of 941,226 shares, compared to its average volume of 1,225,336. Clorox has a 1 year low of $114.68 and a 1 year high of $169.09. The firm has a market cap of $19.75 billion, a PE ratio of 82.40, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The stock's 50 day moving average is $160.25 and its 200 day moving average is $145.43.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox's dividend payout ratio is currently 252.85%.
Insider Activity
In other news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.51% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the stock. BNP Paribas raised shares of Clorox to a "strong sell" rating in a research note on Friday, September 6th. TD Cowen assumed coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a "sell" rating and a $122.00 price target on the stock. DA Davidson reaffirmed a "neutral" rating and issued a $153.00 price target on shares of Clorox in a research note on Friday, September 6th. Barclays raised their price target on shares of Clorox from $130.00 to $137.00 and gave the stock an "underweight" rating in a research note on Friday, October 11th. Finally, Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and raised their price target for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Six research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $150.14.
Read Our Latest Stock Report on CLX
About Clorox
(
Get Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
